Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
various smaller biotech firms
|
| gptkbp:advocates_for |
collaborates with reproductive health advocates
|
| gptkbp:awards |
various industry awards
|
| gptkbp:business_model |
B2 B and B2 C
|
| gptkbp:category |
abortion medication
|
| gptkbp:ceo |
Jessica L. G. Danco
|
| gptkbp:clinical_trial |
ongoing
follows established medical guidelines. |
| gptkbp:collaborations |
non-profit organizations
academic institutions |
| gptkbp:community_engagement |
healthcare education programs
|
| gptkbp:community_support |
local health initiatives
|
| gptkbp:competitors |
other pharmaceutical companies in women's health
|
| gptkbp:distribution |
pharmacies and clinics
|
| gptkbp:employees |
50-100
|
| gptkbp:financial_performance |
private financial reports
|
| gptkbp:financial_products |
gptkb:Company
|
| gptkbp:focus |
women's health
|
| gptkbp:founded |
gptkb:1990
|
| gptkbp:headquarters |
gptkb:Borough
|
| https://www.w3.org/2000/01/rdf-schema#label |
Danco Laboratories
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:innovation |
new drug formulations
|
| gptkbp:invention |
multiple pharmaceutical patents
|
| gptkbp:investment |
research and development
|
| gptkbp:key_people |
gptkb:Dr._David_A._Grimes
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:market |
gptkb:North_America
Mifeprex in 2000 growing in women's health sector |
| gptkbp:marketing_strategy |
direct-to-consumer marketing
|
| gptkbp:mission |
improving access to reproductive health products
|
| gptkbp:notable_products |
gptkb:Mifeprex
|
| gptkbp:partnership |
various healthcare organizations
|
| gptkbp:partnerships |
healthcare advocacy campaigns
|
| gptkbp:products |
none reported
clinically proven stringent testing protocols |
| gptkbp:reach |
international partnerships
|
| gptkbp:receives_funding_from |
grants and investments
|
| gptkbp:regulatory_body |
gptkb:FDA
|
| gptkbp:regulatory_compliance |
gptkb:FDA
|
| gptkbp:research_focus |
contraceptive methods
|
| gptkbp:social_responsibility |
advocacy for reproductive rights
|
| gptkbp:subsidiary |
Danco Pharmaceuticals
|
| gptkbp:sustainability_initiatives |
environmental responsibility programs
|
| gptkbp:training |
ongoing professional development programs
|
| gptkbp:type |
private company
|
| gptkbp:variant |
multiple formulations of Mifeprex
|
| gptkbp:website |
www.dancolabs.com
|
| gptkbp:bfsParent |
gptkb:RU-486
|
| gptkbp:bfsLayer |
5
|